Correlation Between Recursion Pharmaceuticals and Hiru

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Hiru at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Hiru into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Hiru Corporation, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Hiru and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Hiru. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Hiru.

Diversification Opportunities for Recursion Pharmaceuticals and Hiru

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Recursion and Hiru is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Hiru Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hiru and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Hiru. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hiru has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Hiru go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and Hiru

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 0.65 times more return on investment than Hiru. However, Recursion Pharmaceuticals is 1.55 times less risky than Hiru. It trades about 0.11 of its potential returns per unit of risk. Hiru Corporation is currently generating about -0.07 per unit of risk. If you would invest  618.00  in Recursion Pharmaceuticals on September 16, 2024 and sell it today you would earn a total of  77.00  from holding Recursion Pharmaceuticals or generate 12.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  Hiru Corp.

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Hiru 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hiru Corporation has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Recursion Pharmaceuticals and Hiru Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and Hiru

The main advantage of trading using opposite Recursion Pharmaceuticals and Hiru positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Hiru can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hiru will offset losses from the drop in Hiru's long position.
The idea behind Recursion Pharmaceuticals and Hiru Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope